There is growing interest in using biomarkers to screen patients for subclinical CVD to ensure they are detected and treated as early as possible. “Cardiac troponins can be measured with high sensitivity assays to detect...
Racial disparities in the diagnosis, treatment, and outcomes of peripheral artery disease (PAD), according to a study recently published in Advances in Therapy. Keith C. Ferdinand, M.D., from the Tulane University School of...